Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMIPRIL vs RASAGILINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMIPRIL vs RASAGILINE: Safety Overview

Metric RAMIPRIL RASAGILINE
Total FAERS Reports 33,063 2,731
Deaths Reported 3,786 255
Death Rate 11.5% 9.3%
Hospitalizations 17,747 961
Average Patient Age 65.4 yrs 71.0 yrs
% Female Patients 53.1% 46.2%
FDA Approval Date Apr 15, 2014 Apr 9, 2024
Manufacturer GSMS, Incorporated Ascend Laboratories, LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription